Susheel Kodali
Latest contributions
Advanced imaging in structural heart disease interventions
20 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session brings together expert insights on the evolving role of 3D intracardiac echocardiography (ICE) in procedures like LAA closure, Mitral TEER, and Tricuspid TEER—highlighting how this advanced modality is reshaping procedural guidance.
You'll also discover how AI-enabled device detection technology is being integrated into...
Degeneration of TAVI valves: a new target for innovations
19 May 2025 – From EuroPCR 2025
Discover the latest innovations targeting degeneration of TAVI valves, including expert presentations and cutting-edge technologies like The Splitter, an enabler for transcatheter aortic valve-in-valve implantation.
What is new in atrioventricular valves?
19 May 2025 – From EuroPCR 2025
Discover the latest advancements in atrioventricular valve interventions, including innovative transcatheter repair technologies and first-in-human experiences with novel devices.
To repair or to replace the mitral valve: that is the question
16 May 2024 – From EuroPCR 2024
This session provides a comprehensive understanding of both transcatheter edge-to-edge repair (TEER) and transcatheter mitral valve replacement (TMVR) techniques, including their respective advantages, suitability criteria, and clinical outcomes. The session features insights from a surgeon's perspective on the considerations and techniques involved in mitral valve repair...
Pacemaker lead and the tricuspid valve: navigating challenges for optimal care
16 May 2024 – From EuroPCR 2024
This session focuses on the complex interplay between pacemaker leads and the tricuspid valve, addressing the anatomical interactions, procedural challenges, and alternative pacing strategies. Attendees will gain a better understanding of the impact of pacemaker leads on tricuspid regurgitation, the techniques for lead implantation and extraction,...
Patient management before, during, and after transcatheter tricuspid valve replacement
16 May 2024 – From EuroPCR 2024
In this session, explore key aspects of transcatheter tricuspid valve replacement, including the role of right ventricular function, pre-procedural hemodynamics, and factors that contribute to procedural success or failure, and gain insights into patient selection criteria, essential imaging techniques, and best practices for post-procedural care, both...
How to achieve optimal results in tricuspid valve interventions?
15 May 2024 – From EuroPCR 2024
ShortCut leads the way for leaflet modification
14 May 2024 – From EuroPCR 2024
Check out this interview with Philippe Genereux, Danny Dvir and Susheel Kodali, where they discuss the ShortCut trial. Learn about the ShortCut device, the first tool for splitting leaflets in valve-in-valve procedures. Hear key insights, including the dual splitting technique, comparisons between BASILICA and ShortCut, and...
Tricuspid valve intervention in complex scenarios - Tackling tricuspid regurgitation using a multidisciplinary approach
20 Nov 2023 – From PCR London Valves 2023
This session explores the diverse phenotypes of tricuspid regurgitation patients, emphasizing the clinical implications and advocating for a multidisciplinary approach to assessment and treatment. It covers TR clinical courses, investigation pathways, and case scenarios, including atrial fibrillation, heart failure (preserved and reduced ejection fraction), pulmonary hypertension,...
Key questions in tricuspid valve intervention - How do I define treatment options according to individual patient anatomy?
19 Nov 2023 – From PCR London Valves 2023
Explore this tricuspid valve-focused session featuring analysis of four clinical cases: Ebstein anomaly, severe and torrential tricuspid regurgitations, and anterior flail-related torrential regurgitation. Gain insights into optimal treatment selection for each scenario, leveraging pre-procedural imaging for informed decision-making.
Key questions in tricuspid valve intervention - What can cardiologists learn from surgeons when choosing to repair or replace the tricuspid valve?
19 Nov 2023 – From PCR London Valves 2023
Watch this session to explore the latest approaches in surgical and transcatheter tricuspid valve repair and replacement. Gain insights into the influence of right ventricular dysfunction and pulmonary hypertension on post-procedural outcomes, and understand the bleeding risks linked to oral anticoagulation in patients with tricuspid valve...
TRISCEND II: Transcatheter tricuspid valve replacement in patients with severe TR
27 Oct 2023
Mirvat Alasnag interviews Susheel K. Kodali about the results of the TRISCEND II trial which he presented during the TCT Congress 2023 in San Francisco.
Data from the first 150 patients revealed that transcatheter valve replacement effectively improved tricuspid regurgitation and patient symptoms with low adverse events at...
Author
Author
TAVI 2: new devices, procedural refinements
19 May 2023 – From EuroPCR 2023
Seeking a recap of the TAVI Abstract session? Dive into the provided slides containing the main points of the presentation.
Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR™)
16 May 2023 – From EuroPCR 2023
Join this discussion between Christopher Meduri, Susheel Kodali and João Cavalcante covering the early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve called DurAVR™.
This video was recorded for EuroPCR 2023. View more videos and interviews here
Surgical and transcatheter tricuspid intervention: state of the art - LIVE case
29 Nov 2022 – From PCR London Valves 2022
In this PCR London Valves 2022 session, follow 3 stunning case treatments:
- Part 1: Triscupid TEER (Live)
A 78-year-old male with a history of CABG (2015), PM-CRT (2015) and atrial fibrillation, presents a severe TR with an LVEF of 40%, preserved RV function and moderate pulmonary hypertension.
They performed...
Optimal management of right ventricular pacing leads in patients with tricuspid regurgitation
28 Nov 2022 – From PCR London Valves 2022
Consult these presentations to learn more about the consequences of right ventricular pacing lead implantation on tricuspid valve function, the diagnosis and imaging assessment of lead-induced tricuspid regurgitation and the possible treatment options for patients with right ventricular pacing leads and significant tricuspid regurgitation.
Transcatheter mitral valve intervention is progressing more slowly than expected: why is it happening? And what can we do? Root causes, challenges and opportunities
28 Nov 2022 – From PCR London Valves 2022
Consult this session to learn about the latest news in the field of mitral valve intervention and get insights into its current slow progress, which may be caused by clinical, anatomical or technological factors.
Patient selection for tricuspid valve interventions
28 Nov 2022 – From PCR London Valves 2022
Consult this session to learn more about the anatomical assessment of candidates for transcatheter tricuspid valve interventions, to understand the importance of detailed haemodynamic assessment in patients with severe tricuspid regurgitation and to discuss the predictors of clinical outcome after these interventions.
CLASP II TR, TriBAND, bRIGHT: Late-Breaking Trials on tricuspid intervention
27 Nov 2022 – From PCR London Valves 2022
Discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions in this session: the CLASP II TR on transcatheter tricuspid valve repair, the TriBAND study one-year outcomes on transcatheter tricuspid annular reduction, and the bRIGHT trial on real-world outcomes for TEER.
2022: a tipping point in the treatment of mitral regurgitation patients
17 May 2022 – From EuroPCR 2022
With study outcomes and clinical cases, this EuroPCR 2022 session will enable you to discuss the anatomical considerations that define suitable candidates for treatment of mitral regurgitation with the PASCAL platform and highlight key differentiators and tips and tricks for its use.
Transcatheter tricuspid valve interventions: the future
23 Nov 2021 – From PCR London Valves 2021
In this PCR London Valves 2021 session, observe the case of an 84-year-old, not overweight, quite active, female patient with a past history of restrictive cardiomyopathy and permanent atrial fibrillation, who presented with worsening dyspnea and obvious clinical signs of right ventricular heart failure, and discuss the...
Tricuspid valve disease: guidelines and beyond
23 Nov 2021 – From PCR London Valves 2021
Watch this PCR London Valves 2021 session to hear about the latest European guidelines on the management of tricuspid valve disease, understand the details behind these guidelines and how they compare with those elsewhere in the world, and, most importantly, find out how Heart Teams can translate...
TRISCEND Six-Month Outcomes of Transfemoral Tricuspid Valve Replacement in Patients With Tricuspid Regurgitation
07 Nov 2021
Alessandro Sticchi interviews Susheel Kodali, PI of the TRISCEND trial, presented at TCT 2021. They discuss the main results of the study, its impact on the field of Tricuspid and the upcoming TRISCEND II study.
Author
Author
EuroPCR 2021 Hotlines / Late-Breaking Trials: TRILUMINATE, CLASP TR, bRIGHT, TRISCEND, TriBAND, and more!
21 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in TRICUSPID:
- Percutaneous E2E repair for TR: 2-Year outcomes from the TRILUMINATE trial
- Transcatheter tricuspid valve repair: CLASP TR feasibility study 6-month results
- Clinical Response to Transcatheter treatment of tricuspid regurgitation: International TriValve registry
- Baseline characteristics and procedure outcomes from TriClip bRIGHT...
Case Based Learning for the Heart Team: coronary artery disease in TAVI patients
25 Jun 2020 – From PCR e-Course 2020
Watch this case discussion to understand the practical implications of coronary artery disease in TAVI patients, to recognise different situations where this interaction directly impacts on clinical outcomes and to appreciate how to apply this information in your daily clinical practice.
This session was originally presented during...
Case-based learning for the Heart Valve Team: TAVI in pure aortic regurgitation
19 Nov 2019 – From PCR London Valves 2019
Consult this session on TAVI in pure aortic regurgitation to learn more about the anatomy and pathophysiology of aortic regurgitation, the current and emerging surgical treatment options, and the potential role of TAVI in this patient group and how to identify potential candidates for transcatheter intervention.
Spotlight - Challenges for the Heart Team I - A new interventional paradigm for aortic valve disease
18 Nov 2019 – From PCR London Valves 2019
Consult this session on aortic valve disease to learn more about the impact of the latest evidence concerning TAVI vs. SAVR on Heart Team discussions and patient choice (clinical and anatomical characteristics, redistribution of resources and training...), and discover how you and your colleagues can apply this information in...
Late-Breaking Trials at PCR London Valves 2019 - Session 2
18 Nov 2019 – From PCR London Valves 2019
View this session from PCR London Valves 2019 presenting late-breaking trials on incidence, predictors and outcome of structural valve deterioration in transcatheter vs. SAVR, and percutaneous edge-to-edge repair for tricuspid regurgitation.
TAVI device selection for severe aortic stenosis - Session with LIVE case
18 Nov 2019 – From PCR London Valves 2019
Watch this session with a LIVE demonstration from University Hospital of Zurich (Zurich, Switzerland) to learn more about TAVI device selection and « Best practice » implantation of the Portico Valve.
